Cargando…

Development and validation of a nomogram in survival prediction among advanced breast cancer patients

BACKGROUND: The overall survival (OS) among patients with advanced breast cancer (ABC) varies greatly. Although molecular subtype is known as the most important factor in OS differentiation, significant differences in OS among patients with the same molecular subtype still occur, leading to the need...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jianli, Yang, Yaping, Pang, Danmei, Yu, Yunfang, Lin, Xiao, Chen, Kai, Ye, Guolin, Tang, Jun, Hu, Qian, Chai, Jie, Bi, Zhuofei, Ding, Linxiaoxiao, Wu, Wenjing, Zeng, Yinduo, Gui, Xiujuan, Liu, Donggeng, Yao, Herui, Wang, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723627/ https://www.ncbi.nlm.nih.gov/pubmed/33313191 http://dx.doi.org/10.21037/atm-20-3473

Ejemplares similares

Assessing real-world safety concerns of Sacituzumab govitecan: a disproportionality analysis using spontaneous reports in the FDA adverse event reporting system
por: Gui, Xiujuan, et al.
Publicado: (2023)

ARHGAP42 promotes cell migration and invasion involving PI3K/Akt signaling pathway in nasopharyngeal carcinoma
por: Hu, Qian, et al.
Publicado: (2018)

Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients
por: Li, Shunrong, et al.
Publicado: (2017)

Development and validation of a nomogram for predicting the probability of new vertebral compression fractures after vertebral augmentation of osteoporotic vertebral compression fractures
por: Li, Qiujiang, et al.
Publicado: (2021)

LncRNA Uc003xsl.1-Mediated Activation of the NFκB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer
por: Xu, Ying, et al.
Publicado: (2022)

Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer
por: Yang, Yaping, et al.
Publicado: (2019)

Effect of prior cancer history on survival of patients with esophageal carcinoma: a propensity score matching, population-based study
por: Liu, Jingwen, et al.
Publicado: (2022)

Prognostic immune-related gene models for breast cancer: a pooled analysis
por: Zhao, Jianli, et al.
Publicado: (2017)

Development and validation of a nomogram to predict cancer-specific survival of uveal melanoma
por: Zeng, Qiaozhu, et al.
Publicado: (2021)

Novel blood‐based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non‐small‐cell lung cancer: Results from two multicenter, randomized clinical trials
por: Yu, Yunfang, et al.
Publicado: (2020)

Development and validation of a prognostic nomogram for predicting cancer-specific survival in advanced endometrial carcinoma after surgery: a retrospective analysis of the SEER Database
por: Zheng, Chunqin, et al.
Publicado: (2023)

Development and Validation a Nomogram for Predicting Overall Survival in Patients With Intrahepatic Cholangiocarcinoma
por: Yuan, Chen, et al.
Publicado: (2021)

NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition
por: Zhang, Wei, et al.
Publicado: (2019)

Development and validation of a prognostic nomogram to predict overall survival and cancer-specific survival for patients with anaplastic thyroid carcinoma
por: Gui, Weiwei, et al.
Publicado: (2020)

Development and validation of a survival nomogram in patients with primary testicular diffuse large B-cell lymphoma
por: Zhi, Yongjin, et al.
Publicado: (2023)

Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
por: Yu, Yunfang, et al.
Publicado: (2020)

A Nomogram for Predicting the Residual Back Pain after Percutaneous Vertebroplasty for Osteoporotic Vertebral Compression Fractures
por: Li, Qiujiang, et al.
Publicado: (2021)

Survival in Patients with Neuroendocrine Tumours of the Small Intestine: Nomogram Validation and Predictors of Survival
por: Levy, Sonja, et al.
Publicado: (2020)

Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma
por: Wang, Jiao, et al.
Publicado: (2020)

Development and Validation of Survival Nomograms in Patients with Primary Bladder Lymphoma
por: Lin, Junyi, et al.
Publicado: (2022)

Survival nomogram for medulloblastoma and multi-center external validation cohort
por: Li, Xiang, et al.
Publicado: (2023)

Development and validation of nomograms predicting postoperative survival in patients with chromophobe renal cell carcinoma
por: Li, Shuaishuai, et al.
Publicado: (2022)

Development and validation of a radiomics nomogram for diagnosis of malignant pleural effusion
por: Wei, Mingzhu, et al.
Publicado: (2023)

Construction and validation a nomogram to predict overall survival for colorectal signet ring cell carcinoma
por: Diao, Jian-dong, et al.
Publicado: (2021)

Development and external validation of a dynamic nomogram to predict the survival for adenosquamous carcinoma of the pancreas
por: Ren, Chao, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Predicting Survival in Patients with Thyroid Cancer
por: Wen, Qian, et al.
Publicado: (2019)

A validated survival nomogram for early-onset diffuse gastric cancer
por: Liao, Fei, et al.
Publicado: (2020)

Development and validation of a nomogram to predict the overall survival of patients with neuroblastoma
por: Liu, Qinglin, et al.
Publicado: (2020)

Establishment and validation of a novel nomogram for survival prediction of ovarian carcinosarcoma
por: Liu, Yi, et al.
Publicado: (2022)

Nomograms predicting survival for all four subtypes of breast cancer: a SEER-based population study
por: Chu, Jianli, et al.
Publicado: (2020)

Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma
por: Zheng, Wenwen, et al.
Publicado: (2020)

Development and validation of a simple-to-use nomogram to predict the deterioration and survival of patients with COVID-19
por: Zeng, Zhiyong, et al.
Publicado: (2021)

Development and Validation of the Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients With Synovial Sarcoma
por: Song, Zhengqing, et al.
Publicado: (2022)

Impact of body mass index and its change on survival outcomes in patients with early breast cancer: A pooled analysis of individual-level data from BCIRG-001 and BCIRG-005 trials
por: Chen, Haizhu, et al.
Publicado: (2023)

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer
por: Liu, Jieqiong, et al.
Publicado: (2022)

Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases
por: Zhang, Ye, et al.
Publicado: (2019)

Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
por: He, Zifan, et al.
Publicado: (2020)

Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study
por: Ren, Wei, et al.
Publicado: (2022)

Immune gene patterns and characterization of the tumor immune microenvironment associated with cancer immunotherapy efficacy
por: Lin, Lili, et al.
Publicado: (2023)

Radiomic and clinical data integration using machine learning predict the efficacy of anti-PD-1 antibodies-based combinational treatment in advanced breast cancer: a multicentered study
por: Zhao, Jianli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5mo4unh6qtkvg4evsnne8njlle